BCH just had one of its loudest 24 hours all year, and this time it's not just hype.
Bitcoin Cash is up over 30% in a day and roughly 54% over the past week, trading near $357. The trigger: CME Group confirmed it's launching standard and micro Bitcoin Cash futures on October 19, pending regulatory sign-off. A day later, Grayscale filed an amended application to convert its Bitcoin Cash Trust into a spot ETF on NYSE Arca, still awaiting SEC approval.
Here's my take. Futures listings on a regulated exchange like CME aren't a meme catalyst, they're plumbing for institutional money that couldn't touch BCH before. Combine that with a live ETF filing and you get two separate paths for traditional capital to enter at once.
That's usually a bigger deal than a single exchange listing or influencer pump, because it changes who's allowed to buy, not just sentiment.
The risk nobody's pricing in loudly enough: both catalysts are still pending approval. CME's October 19 date isn't locked, and
Grayscale's SEC filing has no set timeline. A chunk of this move is the market front-running approval that hasn't happened yet, so I'd treat the current price as reflecting hope, not certainty.
Watching how BCH holds above the $300-320 zone over the next week tells you a lot about whether this becomes structural buying or just a fast fade.
Follow me for more trading content.
#BCH $BCH #altcoins
Bitcoin Cash is up over 30% in a day and roughly 54% over the past week, trading near $357. The trigger: CME Group confirmed it's launching standard and micro Bitcoin Cash futures on October 19, pending regulatory sign-off. A day later, Grayscale filed an amended application to convert its Bitcoin Cash Trust into a spot ETF on NYSE Arca, still awaiting SEC approval.
Here's my take. Futures listings on a regulated exchange like CME aren't a meme catalyst, they're plumbing for institutional money that couldn't touch BCH before. Combine that with a live ETF filing and you get two separate paths for traditional capital to enter at once.
That's usually a bigger deal than a single exchange listing or influencer pump, because it changes who's allowed to buy, not just sentiment.
The risk nobody's pricing in loudly enough: both catalysts are still pending approval. CME's October 19 date isn't locked, and
Grayscale's SEC filing has no set timeline. A chunk of this move is the market front-running approval that hasn't happened yet, so I'd treat the current price as reflecting hope, not certainty.
Watching how BCH holds above the $300-320 zone over the next week tells you a lot about whether this becomes structural buying or just a fast fade.
Follow me for more trading content.
#BCH $BCH #altcoins
